ARCHIVES

NCAB Considers Discrimination Against Patients, Minority Rates, Smokeless Tobacco

This article is from The Cancer Letter archive.

Vol. 11 No. 15 | April 12, 1985

Download PDF Visit The Full Archive

Related Articles

Patient Harm—Including One Death—Cited As Faculty Challenges MD Anderson Leadership

September 20, 2013

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

August 3, 2001

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

DePinho’s Letter to CPRIT’s Gimson, And Gimson’s Response

June 1, 2012

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009